SINOCARE INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.17 CNY | 0.00% |
|
+16.32% | -23.78% |
| 04-26 | Sinocare Inc. Proposes Final Dividend for 2023 | CI |
| 04-25 | Sinocare Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2024 * | 4.98B 688M 941M | Sales 2025 * | 5.79B 798M 1.09B | Capitalization | 12.89B 1.78B 2.43B |
|---|---|---|---|---|---|
| Net income 2024 * | 516M 71.21M 97.35M | Net income 2025 * | 642M 88.6M 121M | EV / Sales 2024 * | 2.58 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 2.23 x |
| P/E ratio 2024 * |
25.3
x | P/E ratio 2025 * |
20.4
x | Employees | 3,756 |
| Yield 2024 * |
1.01% | Yield 2025 * |
1.12% | Free-Float | 21.03% |
More Fundamentals
* Assessed data
More news
| 1 week | +16.32% | ||
| Current month | +10.54% | ||
| 1 month | +11.93% | ||
| 3 months | -7.84% | ||
| 6 months | -17.87% | ||
| Current year | -23.78% |
1 week
19.81
23.97
1 month
19.1923.97
Current year
19.1930.40
1 year
19.1933.28
3 years
13.3039.21
5 years
9.9853.69
10 years
9.6253.69
| Managers | Title | Age | Since |
|---|---|---|---|
Shao Bo Li
CEO | Chief Executive Officer | 59 | 02-07-31 |
Bo Shen Ou Yang
CHM | Chairman | 46 | 09-07-31 |
Chun Geng Chen
BRD | Director/Board Member | 47 | 16-11-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shao Bo Li
CEO | Chief Executive Officer | 59 | 02-07-31 |
Hong Yuan
BRD | Director/Board Member | 66 | 19-12-22 |
Xi Xiong Kang
BRD | Director/Board Member | 72 | 19-12-22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +1.11% | - | |
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 23.17 | 0.00% | 9,028,804 |
| 24-04-25 | 23.17 | +1.53% | 5,330,576 |
| 24-04-24 | 22.82 | +0.09% | 6,375,413 |
| 24-04-23 | 22.8 | +6.10% | 12,979,190 |
| 24-04-22 | 21.49 | +7.88% | 8,779,506 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
Sinocare Inc. is a China-based company principally engaged in the research, development, production and distribution of blood sugar monitoring systems. The Company mainly provides micro blood instant blood sugar monitoring systems including blood sugar testing instruments and related blood sugar testing strips, as well as blood sugar testing systems and mobile blood sugar instruments, among others. The Company also provides diabetes management information systems. It distributes its products within domestic market and to overseas markets under the brand name of SANNUO.
Calendar
2024-05-21
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
23.17
CNY
Average target price
31.71
CNY
Spread / Average Target
+36.84%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.78% | 1.78B | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.36% | 26.25B | |
| +2.07% | 26.48B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- 300298 Stock
